SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-24-011753
Filing Date
2024-08-06
Accepted
2024-08-06 16:07:08
Documents
5
Period of Report
2024-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp216020_6k.htm 6-K 17428
2 EXHIBIT 1.1 dp216020_ex0101.htm EX-1.1 223212
3 EXHIBIT 5.1 dp216020_ex0501.htm EX-5.1 25918
4 GRAPHIC image_001.jpg GRAPHIC 2638
5 GRAPHIC image_002.jpg GRAPHIC 12290
  Complete submission text file 0000950103-24-011753.txt   288446
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 241179188
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)